Search
Foslinanib
go.drugbank.com/drugs/DB16172InvestigationalFoslinanib is under investigation in clinical trial NCT03600233 (Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors).
2,4-thiazolidinedione
go.drugbank.com/drugs/DB11898InvestigationalThiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2.
Golvatinib
go.drugbank.com/drugs/DB11977InvestigationalGolvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
MC-1
go.drugbank.com/drugs/DB05315ExperimentalMedicure's MC-1 drug is a cardio-protectant, designed to reduce the damage to the heart when arteries are blocked and when they are subsequently reopened after bypass surgery.
Riltozinameran
go.drugbank.com/drugs/DB17095ApprovedInvestigationalIt is administered in combination with [tozinameran] for active immunization against COVID-19 caused by SARS-CoV-2, including infection caused by Omicron BA.1[L45419]
Vapendavir
go.drugbank.com/drugs/DB05181InvestigationalBTA798 is an antiviral for the treatment of HRV, the common cold virus, known to cause significant clinical complications in sufferers of Asthma and Chronic Obstructive Pulmonary Disease.
ZKN-013
go.drugbank.com/drugs/DB32582ExperimentalZKN-013 is a readthrough inducer under investigation for rare dermatological diseases.[L56075]
VO659
go.drugbank.com/drugs/DB18160InvestigationalVO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.
VG161
go.drugbank.com/drugs/DB18469InvestigationalVG161 is an oncolytic virus therapy under investigation for the treatment of cholangiocarcinoma.
Pristimerin
go.drugbank.com/drugs/DB17049ExperimentalPristimerin is a quinone methide triterpenoid researched for its anti-cancer potential.[A253107]